Opportunity Information: Apply for HRSA 10 094
Apply for HRSA 10 094
- The Health Resources and Services Administration in the health sector is offering a public funding opportunity titled "Sickle Cell Treatment Demonstration Program" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.365 Sickle Cell Treatment Demonstration Program.
- This funding opportunity was created on Mar 3, 2010 and posted on Mar 3, 2010.
- Applicants must submit their applications by Apr 19, 2010. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $400,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $400,000.00 in funding.
- The number of recipients for this funding is limited to 4 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Eligible entities for this grant program will include any Federally qualified health center, non profit hospital or clinic, or university health center providing primary health care that (1) has a collaborative agreement with a community based sickle cell disease organization or a nonprofit entity with experience in working with individuals with sickle cell disease and (2) can demonstrate that it, this collaborative entity, or the experts described in section 712(c)(2)(C) of the American Jobs Creation Act of 2004, has at least five (5) years experience working with individuals with sickle cell disease. Faith based and community based organizations that meet these qualifications are eligible to apply. For the Networks, priority will be given to eligible entities that are 1) Federally qualified health centers that have a partnership or other arrangement with a comprehensive Sickle Cell Disease treatment center or 2) Federally qualified health centers that intend to develop a partnership or other arrangement with a comprehensive Sickle Cell Disease treatment center.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Sickle Cell Treatment Demonstration Program (Funding Opportunity Number HRSA-10-094) is a Health Resources and Services Administration (HRSA) discretionary grant program offered through a cooperative agreement. Its central aim is to strengthen how communities prevent and treat sickle cell disease by building practical, coordinated systems of care rather than isolated services. The program focuses on improving the overall delivery of sickle cell services by organizing care across providers, expanding access to genetic counseling and genetic testing, bundling and coordinating technical and support services, and training health professionals so patients can receive more consistent, informed, and effective care. In plain terms, the grant is meant to help eligible health care organizations set up or enhance local and regional “care networks” that make it easier for people with sickle cell disease to get the right services at the right time, and to ensure clinicians have better preparation to manage sickle cell across the lifespan.
Funding for the opportunity was limited and competitive. HRSA expected to make about four awards, with an estimated total program funding amount of $400,000. Individual awards ranged from a floor of $100,000 up to a ceiling of $400,000, and there was no cost-sharing or matching requirement, meaning applicants were not required to contribute non-federal funds to be eligible. The announcement was posted on March 3, 2010, and the application closing date was April 19, 2010, with the opportunity later archived on June 18, 2010. The program is associated with CFDA number 93.365 (Sickle Cell Treatment Demonstration Program), which is the federal catalog identifier used for tracking and reference.
Eligibility was targeted to organizations that provide primary health care and can demonstrate established, real-world experience serving individuals with sickle cell disease. Eligible applicants included Federally Qualified Health Centers (FQHCs), nonprofit hospitals or clinics, and university health centers, as long as they met two key conditions. First, the applicant had to have a collaborative agreement with a community-based sickle cell disease organization or another nonprofit entity experienced in working with people who have sickle cell disease. Second, the applicant (or its collaborating entity, or qualified experts referenced in the American Jobs Creation Act of 2004) had to demonstrate at least five years of experience working with individuals with sickle cell disease. Faith-based and community-based organizations were also eligible as long as they met the same qualifications, emphasizing that HRSA was open to trusted local institutions with a track record in this area, not just traditional medical centers.
The opportunity also placed special emphasis on building partnerships and networks that connect primary care sites with comprehensive sickle cell disease treatment centers. For network-based efforts, HRSA indicated a preference for FQHCs that already had a partnership or arrangement with a comprehensive sickle cell treatment center, or FQHCs that intended to develop such a partnership. This priority signals that HRSA wanted awardees to bridge gaps between community-based primary care and specialized sickle cell expertise, so that patients could benefit from both accessible front-line care and advanced, condition-specific management. Overall, the program’s design points toward system-building: aligning clinical services, supportive services, counseling and testing, and workforce development into a coordinated approach that can be replicated and sustained beyond the grant period.
For applicants or stakeholders who needed help accessing the full announcement, HRSA provided support through its call center and email contact (CallCenter@HRSA.GOV), with phone options including 877-Go4-HRSA (877-464-4772) and 301-998-7373. The original listing also included an external link to HRSA’s grant posting page for the full details and application requirements.
Frequently Asked Questions (FAQs)
What is the Sickle Cell Treatment Demonstration Program (HRSA-10-094)?
The Sickle Cell Treatment Demonstration Program (Funding Opportunity Number HRSA-10-094) is a Health Resources and Services Administration (HRSA) discretionary grant program offered through a cooperative agreement. The program is designed to strengthen how communities prevent and treat sickle cell disease by building coordinated, practical systems of care rather than stand-alone or isolated services.
What is the main goal of this grant opportunity?
The central aim is to improve the overall delivery of sickle cell services in communities by organizing care across providers and building local and regional networks that help people with sickle cell disease get the right services at the right time. A major focus is creating coordinated systems that improve consistency and effectiveness of care across the lifespan.
What kinds of activities or improvements does the program emphasize?
Based on the program description, the grant emphasizes: coordinating care across providers, expanding access to genetic counseling and genetic testing, bundling and coordinating technical and support services, and training health professionals to deliver more informed and consistent sickle cell care.
What does HRSA mean by building "care networks" for sickle cell disease?
In plain terms, the opportunity is meant to help eligible organizations set up or enhance local and regional care networks that connect services and providers so care is coordinated rather than fragmented. The intent is to make it easier for patients to navigate services and for clinicians to manage sickle cell disease with better preparation and support.
What type of funding mechanism is used?
This HRSA opportunity is offered as a cooperative agreement under a discretionary grant program.
How many awards did HRSA expect to make?
HRSA expected to make about four awards under this opportunity.
What was the estimated total funding available for the program?
The estimated total program funding amount was $400,000.
What was the minimum and maximum award amount?
Individual awards ranged from a floor of $100,000 up to a ceiling of $400,000.
Was there a cost-sharing or matching requirement?
No. The opportunity stated there was no cost-sharing or matching requirement, meaning applicants were not required to contribute non-federal funds to be eligible.
When was the opportunity posted and when was the application due?
The announcement was posted on March 3, 2010, and the application closing date was April 19, 2010.
Is this funding opportunity still open?
No. The opportunity was later archived on June 18, 2010.
What is the CFDA number associated with this program?
The program is associated with CFDA number 93.365, which is the federal catalog identifier used for tracking and reference for the Sickle Cell Treatment Demonstration Program.
Who was eligible to apply?
Eligibility was targeted to organizations that provide primary health care and can demonstrate established experience serving individuals with sickle cell disease. Examples of eligible applicants included Federally Qualified Health Centers (FQHCs), nonprofit hospitals or clinics, and university health centers, as long as they met the required conditions described in the announcement.
Were faith-based and community-based organizations eligible?
Yes. Faith-based and community-based organizations were also eligible as long as they met the same qualifications, including the collaboration and experience requirements.
What collaboration requirement did applicants have to meet?
Applicants had to have a collaborative agreement with a community-based sickle cell disease organization or another nonprofit entity experienced in working with people who have sickle cell disease.
What experience requirement did applicants have to meet?
The applicant (or its collaborating entity, or qualified experts referenced in the American Jobs Creation Act of 2004) had to demonstrate at least five years of experience working with individuals with sickle cell disease.
Did HRSA prioritize any specific kinds of partnerships or network relationships?
Yes. The opportunity placed special emphasis on building partnerships and networks that connect primary care sites with comprehensive sickle cell disease treatment centers.
Was there a preference for Federally Qualified Health Centers (FQHCs)?
For network-based efforts, HRSA indicated a preference for FQHCs that already had a partnership or arrangement with a comprehensive sickle cell treatment center, or FQHCs that intended to develop such a partnership.
Why did HRSA emphasize connecting primary care with comprehensive treatment centers?
The stated priority signals that HRSA wanted awardees to bridge gaps between community-based primary care and specialized sickle cell expertise so patients could benefit from accessible front-line care as well as advanced, condition-specific management.
What was HRSA trying to move away from with this program design?
The program description emphasizes building coordinated systems of care rather than isolated services, pointing toward system-building that aligns clinical services, supportive services, counseling and testing, and workforce development into a coordinated approach.
How could applicants or stakeholders get help accessing the full announcement?
HRSA provided support through its call center and an email contact. The email listed was CallCenter@HRSA.GOV, and phone options included 877-Go4-HRSA (877-464-4772) and 301-998-7373.
Where could someone find the full details and application requirements?
The original listing included an external link to HRSA's grant posting page for the full details and application requirements (the specific URL was not provided in the summary information here).
Browse more opportunities from the same category: Health
Next opportunity: Small Business Innovation Research Program Phase I Solicitation FY 2011 (Release 1)
Previous opportunity: MARC Undergraduate Student Training in Academic Research (U STAR) National Research Service Award (NRSA) Institutional Research Training Grant (T34)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for HRSA 10 094
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (HRSA 10 094) also looked into and applied for these:
| Funding Opportunity |
|---|
| Improved Diagnostics for Lyme Borreliosis (U01) Apply for RFA CK 10 005 Funding Number: RFA CK 10 005 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $250,000 |
| Assessment of Post treatment Lyme disease Syndrome (PLDS) (R01) Apply for RFA CK 10 004 Funding Number: RFA CK 10 004 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $300,000 |
| Long Term Outcomes of Infants Identified with Congenital CMV Infection (U01) Apply for RFA IP 10 006 Funding Number: RFA IP 10 006 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $550,000 |
| MAPGen Knowledge Base (MAPGenKB) and Coordination Center (U01) Apply for RFA HL 11 004 Funding Number: RFA HL 11 004 Agency: National Institutes of Health Category: Health Funding Amount: $650,000 |
| Cooperative Agreement with the Kenya Ministry of Public Health and Sanitation (KMOPHS) Apply for CDC RFA GH10 1004 Funding Number: CDC RFA GH10 1004 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Supporting the Republican Blood Center (RBC) in the Implementation of Blood Safety Activities in the Republic of Uzbekistan under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10170 Funding Number: CDC RFA PS10 10170 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| Providing HIV Prevention, Treatment, and Care Services to Incarcerated Population in the Kyrgyz Republic under the President s Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10171 Funding Number: CDC RFA PS10 10171 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| PPHF 2012 Public Health Workforce Association of Public Health Laboratories (APHL) financed solely by 2012 Prevention and Public Health Funds Apply for CDC RFA HM10 1001 Funding Number: CDC RFA HM10 1001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,983,074 |
| Providing HIV Prevention, Treatment, and Care Services to the Incarcerated Population in the Republic of Kazakhstan under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10172 Funding Number: CDC RFA PS10 10172 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| Providing HIV Prevention, Treatment, and Care Services to the Incarcerated Population in the Republic of Tajikistan under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10173 Funding Number: CDC RFA PS10 10173 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| Developing a Regional Public Health Surveillance and Laboratory Network for Central America with the Secretara General del Sistema de la Integracin Centroamericana (SG SICA) / Consejo de Ministros de Salud de Centroamrica (COMISCA) Apply for CDC RFA GH10 1005 Funding Number: CDC RFA GH10 1005 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Hepatitis C Treatment Expansion Initiative Demonstration Sites Apply for HRSA 10 090 Funding Number: HRSA 10 090 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Poison Center Support and Enhancement Grant Program, Incentive Grants Apply for HRSA 10 051 Funding Number: HRSA 10 051 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Improving HIV Prevention Initiatives in Communities in the Republic of Zambia under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10109 Funding Number: CDC RFA PS10 10109 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,500,000 |
| ARRA CHARN Central Data Management Coordination Center Apply for HRSA 10 206 Funding Number: HRSA 10 206 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| EMSC Targeted Issue Grants Apply for HRSA 10 062 Funding Number: HRSA 10 062 Agency: Health Resources and Services Administration Category: Health Funding Amount: $300,000 |
| Global Partnerships with Non Governmental Organizations (NGO s) Apply for CDC FOA GH10 1003 Funding Number: CDC FOA GH10 1003 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| AETC National Multicultural Center Apply for HRSA 10 149 Funding Number: HRSA 10 149 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| NIAID Advanced Technology SBIR (NIAID AT SBIR R43/R44) Apply for PA 10 123 Funding Number: PA 10 123 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| NIAID Advanced Technology STTR (NIAID AT STTR R41/R42) Apply for PA 10 124 Funding Number: PA 10 124 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "HRSA 10 094", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.